• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例伴有t(3;8)(q27;q24)的双打击CD10阴性B细胞淋巴瘤,导致BCL6和MYC基因座并列,临床预后良好。

A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome.

作者信息

Sanders Lucinda, Jayne Sandrine, Kennedy Ben, Miall Fiona, Aukema Sietse M, Siebert Reiner, Wagner Simon D, Dyer Martin J S

机构信息

Department of Haematology, University Hospitals of Leicester, Leicester LE1 5WW, UK.

Ernest and Helen Scott Haematological Research Institute and Department of Biochemistry, University of Leicester, Leicester LE1 9HN, UK.

出版信息

Case Rep Hematol. 2014;2014:120714. doi: 10.1155/2014/120714. Epub 2014 Oct 1.

DOI:10.1155/2014/120714
PMID:25349747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4198823/
Abstract

The WHO classification of lymphomas allows for a group of diseases that have features intermediate between those of Burkitt lymphoma and diffuse large B-cell lymphoma. These are a diverse group of diseases whose genetics and clinical course are yet to be fully described. We report an unusual case of high grade B-cell lymphoma, intermediate between DLBCL and BL, lacking CD10 expression in which the chromosomal translocation t(3;8)(q27;q24) was found to be the sole chromosomal abnormality. FISH analysis demonstrated juxtaposition of the BCL6 and MYC loci without obvious involvement of the IGH locus, suggesting constitutive MYC expression due to promoter substitution. The patient responded to intensive chemotherapy and remains in remission two years after finishing therapy.

摘要

世界卫生组织(WHO)对淋巴瘤的分类中包括一组疾病,其特征介于伯基特淋巴瘤和弥漫性大B细胞淋巴瘤之间。这是一组多样的疾病,其遗传学和临床病程尚未完全阐明。我们报告了一例罕见的高级别B细胞淋巴瘤病例,介于弥漫性大B细胞淋巴瘤和伯基特淋巴瘤之间,缺乏CD10表达,其中发现染色体易位t(3;8)(q27;q24)是唯一的染色体异常。荧光原位杂交(FISH)分析显示BCL6和MYC基因座并列,而IGH基因座未明显受累,提示由于启动子替代导致MYC组成性表达。该患者对强化化疗有反应,完成治疗两年后仍处于缓解状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166a/4198823/8f8becf4d0ae/CRIHEM2014-120714.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166a/4198823/8f8becf4d0ae/CRIHEM2014-120714.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166a/4198823/8f8becf4d0ae/CRIHEM2014-120714.001.jpg

相似文献

1
A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome.一例伴有t(3;8)(q27;q24)的双打击CD10阴性B细胞淋巴瘤,导致BCL6和MYC基因座并列,临床预后良好。
Case Rep Hematol. 2014;2014:120714. doi: 10.1155/2014/120714. Epub 2014 Oct 1.
2
Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.由于 t(3;8)(q27;q24)导致的具有假性双打击 BCL6-MYC 易位的淋巴瘤与生发中心免疫表型、结外累及和频繁的 BCL2 易位有关。
Hum Pathol. 2018 Oct;80:192-200. doi: 10.1016/j.humpath.2018.06.006. Epub 2018 Jun 11.
3
A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.一例原发性骨髓B细胞淋巴瘤中出现的一种新的五重易位,即t(3;9;13;8;14)(q27;p13;q32;q24;q32),同时伴有MYC和BCL6重排。
Cancer Genet. 2011 Sep;204(9):501-6. doi: 10.1016/j.cancergen.2011.08.017.
4
Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.伯基特淋巴瘤(BL):对过去根据免疫组织化学和荧光原位杂交诊断为BL或伯基特样淋巴瘤的39例淋巴瘤进行重新分类。
Cesk Patol. 2011 Jul;47(3):106-14.
5
Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.滤泡性淋巴瘤转化为伴有MYC和BCL2易位的高级别B细胞淋巴瘤以及伯基特淋巴瘤和急性淋巴细胞白血病的重叠特征:一例报告及文献综述
Clin Med Insights Blood Disord. 2017 Feb 28;10:1179545X17692544. doi: 10.1177/1179545X17692544. eCollection 2017.
6
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.具有 BCL6 和 MYC 易位的双打击 B 细胞淋巴瘤是侵袭性的,常为结外淋巴瘤,与 BCL2 双打击 B 细胞淋巴瘤不同。
Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.
7
Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.伯基特淋巴瘤及其他恶性淋巴瘤中涉及8q24的易位:基于当今知识的细胞遗传学历史回顾
Leukemia. 2009 Feb;23(2):225-34. doi: 10.1038/leu.2008.281. Epub 2008 Oct 16.
8
A double-hit High-grade B-cell lymphoma with three-way translocation t(3;8;14)(q27;q24;q32) involving BCL6, MYC, and IGH.一种伴有涉及BCL6、MYC和IGH的三向易位t(3;8;14)(q27;q24;q32)的双打击高级别B细胞淋巴瘤。
Clin Case Rep. 2018 Oct 26;6(12):2411-2415. doi: 10.1002/ccr3.1871. eCollection 2018 Dec.
9
Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.伴有t(3;7)(q27;p12)和t(8;14)(q24;q32)易位的原发性胸壁MYC/BCL6双打击淋巴瘤
Intern Med. 2019 Jul 15;58(14):2073-2077. doi: 10.2169/internalmedicine.2532-18. Epub 2019 Mar 28.
10
MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.MYC/BCL6 双打击淋巴瘤(DHL):一种与侵袭性临床病程和不良预后相关的肿瘤。
Histopathology. 2016 Jun;68(7):1090-8. doi: 10.1111/his.12884. Epub 2015 Dec 8.

引用本文的文献

1
Gene Transactivation and Transrepression in MYC-Driven Cancers.MYC 驱动型癌症中的基因激活和转录抑制。
Int J Mol Sci. 2021 Mar 27;22(7):3458. doi: 10.3390/ijms22073458.
2
Primary testicular diffuse large B-cell lymphoma: Case series.原发性睾丸弥漫性大B细胞淋巴瘤:病例系列
Medicine (Baltimore). 2020 Mar;99(12):e19463. doi: 10.1097/MD.0000000000019463.
3
Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.累及颅骨和附属器病变的双打击淋巴瘤(MYC和BCL6):一例报告并文献复习

本文引用的文献

1
Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.伴有 BCL6 和 MYC 易位的侵袭性 B 细胞淋巴瘤具有独特的临床病理特征。
Am J Clin Pathol. 2014 Sep;142(3):339-46. doi: 10.1309/AJCPBWVHTF7RRSA4.
2
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.MYC 基因重排有助于利妥昔单抗-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者的风险分层。
Mod Pathol. 2014 Jul;27(7):958-71. doi: 10.1038/modpathol.2013.214. Epub 2013 Dec 13.
3
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
Am J Case Rep. 2018 Aug 30;19:1035-1041. doi: 10.12659/AJCR.909400.
4
Cryptic t(3;8)(q27;q24) and/or MYC-BCL6 linkage associated with MYC expression by immunohistochemistry is frequent in multiple-hit B-cell lymphomas.隐匿性t(3;8)(q27;q24)和/或通过免疫组织化学与MYC表达相关的MYC-BCL6连锁在多次打击B细胞淋巴瘤中很常见。
Blood Cancer J. 2017 Jun 30;7(6):e578. doi: 10.1038/bcj.2017.59.
除分子型伯基特淋巴瘤外的成人MYC易位阳性成熟B细胞淋巴瘤的生物学特征
Haematologica. 2014 Apr;99(4):726-35. doi: 10.3324/haematol.2013.091827. Epub 2013 Oct 31.
4
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.免疫组织化学标志物和算法在免疫化疗治疗弥漫性大 B 细胞淋巴瘤患者中的预后意义。
Histopathology. 2013 Dec;63(6):788-801. doi: 10.1111/his.12223. Epub 2013 Oct 1.
5
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.具有 BCL6 和 MYC 易位的双打击 B 细胞淋巴瘤是侵袭性的,常为结外淋巴瘤,与 BCL2 双打击 B 细胞淋巴瘤不同。
Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.
6
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.通过整合基因组、外显子组和转录组测序鉴定伯基特淋巴瘤中 ID3 基因的反复突变。
Nat Genet. 2012 Dec;44(12):1316-20. doi: 10.1038/ng.2469. Epub 2012 Nov 11.
7
TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.儿童伯基特淋巴瘤中 TP53 通路分析显示,在一部分病例中,只有 MDM4 表达增加是检测到的 TP53 通路异常。
Br J Haematol. 2012 Sep;158(6):763-71. doi: 10.1111/j.1365-2141.2012.09243.x. Epub 2012 Jul 27.
8
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.患者诊断时的年龄与弥漫性大 B 细胞淋巴瘤的分子特征有关。
Blood. 2012 Feb 23;119(8):1882-7. doi: 10.1182/blood-2011-10-388470. Epub 2012 Jan 11.
9
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.评估利妥昔单抗联合 CODOX-M/IVAC 方案治疗伯基特淋巴瘤的疗效:一项回顾性分析。
Ann Oncol. 2011 Aug;22(8):1859-64. doi: 10.1093/annonc/mdq677. Epub 2011 Feb 21.
10
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.两例三打击淋巴瘤中的(3;8)(q27;q24)易位
Cancer Genet Cytogenet. 2010 Dec;203(2):328-32. doi: 10.1016/j.cancergencyto.2010.08.018.